Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

Recent & Breaking News (NYSEAM:ZOM)

Zomedica Announces Second Quarter 2019 Financial Results

GlobeNewswire August 8, 2019

Zomedica Announces TRUFORMAâ„¢ Assay Updates and R&D Expansion

GlobeNewswire August 7, 2019

Zomedica's Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4

GlobeNewswire July 25, 2019

Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline

GlobeNewswire July 17, 2019

Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform

GlobeNewswire June 13, 2019

Zomedica to Present at Raymond James Life Sciences and MedTech Conference

GlobeNewswire June 12, 2019

Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares

GlobeNewswire June 10, 2019

Zomedica Announces First Quarter 2019 Financial Results

GlobeNewswire May 10, 2019

Zomedica Announces Private Placement of Preferred Shares

GlobeNewswire May 10, 2019

Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares

GlobeNewswire March 26, 2019

Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares

GlobeNewswire March 25, 2019

Zomedica Initiates ZM-006 Pilot Efficacy Study and Provides Corporate Updates

GlobeNewswire March 5, 2019

Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results

GlobeNewswire February 26, 2019

Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs

GlobeNewswire January 15, 2019

Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update

GlobeNewswire January 14, 2019

Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program

GlobeNewswire December 20, 2018

IncellDx and Zomedica Sign Diagnostic CTC Assay Development Agreement for Canine Cancer

PR Newswire December 19, 2018

Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform

GlobeNewswire November 27, 2018

Zomedica Announces $10 Million Private Offering of Common Shares

GlobeNewswire November 27, 2018

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results

GlobeNewswire November 13, 2018